Fundies.
English

MILESTONE PHARMACEUTICALS INC.

EDGAR
MIST Current report (8-K) · filed 2026-10-28

56 filing records in this dataset, filed from 2017-07-25 to 2026-10-28. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

600 thousand Unit_Standard_USD_KM96fwISsEeC3iuoT5wSyg

2026 Q2 · Unit_Standard_USD_KM96fwISsEeC3iuoT5wSyg

Exact inputs and evidence
  • Revenue: 600000 Unit_Standard_USD_KM96fwISsEeC3iuoT5wSyg Source

Operating margin

-4,271.67%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -25630000 Unit_Standard_USD_KM96fwISsEeC3iuoT5wSyg Source
  • Revenue: 600000 Unit_Standard_USD_KM96fwISsEeC3iuoT5wSyg Source
Cash and cash equivalents
170 million Unit_Standard_USD_KM96fwISsEeC3iuoT5wSyg Source
Exact value

169728000 Unit_Standard_USD_KM96fwISsEeC3iuoT5wSyg

Long-term debt including current maturities
59.2 million Unit_Standard_USD_KM96fwISsEeC3iuoT5wSyg Source
Exact value

59207000 Unit_Standard_USD_KM96fwISsEeC3iuoT5wSyg

Shares outstanding
124 million Unit_Standard_shares_VmQNajPCF0i279IJ5tiaGA Source
Exact value

124497980 Unit_Standard_shares_VmQNajPCF0i279IJ5tiaGA

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-28.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 2 of 11 periods available· newest 2025-12-31
  • Net income: 2 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 2 of 11 periods available· newest 2025-12-31
  • Total assets: Multiple units; comparison withheld· newest 2025-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Current assets: Multiple units; comparison withheld· newest 2025-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
  • Long-term debt including current maturities: Multiple units; comparison withheld· newest 2025-12-31
  • Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 21.54 million

    Prior period

    −Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 41.52 million

    –

    Current period

    −Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 63.06 million

    –

    Exact inputs and evidence

    -63058000 − -41519000 = -21539000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

    -41519000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -63058000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 20.19 million

    Prior period

    −Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 28.85 million

    –

    Current period

    −Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 49.04 million

    –

    Exact inputs and evidence

    -49041000 − -28848000 = -20193000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

    -28848000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -49041000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +815.2%

    Prior period

    Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 33,000

    –

    Current period

    Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 302,000

    –

    Exact inputs and evidence

    302000 − 33000 = 269000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

    33000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    302000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2024 2024-01-01 – 2024-12-31
−Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 41.52 million
Exact value

Exact value: -41519000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

2024-01-01 – 2024-12-31: -41519000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 28.85 million
Exact value

Exact value: -28848000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

2024-01-01 – 2024-12-31: -28848000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 33,000
Exact value

Exact value: 33000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

2024-01-01 – 2024-12-31: 33000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 28.88 million
Calculation and evidence

-28848000 − 33000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

Exact free cash flow: -28881000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 63.06 million
Exact value

Exact value: -63058000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

2025-01-01 – 2025-12-31: -63058000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 49.04 million
Exact value

Exact value: -49041000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

2025-01-01 – 2025-12-31: -49041000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 302,000
Exact value

Exact value: 302000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

2025-01-01 – 2025-12-31: 302000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ 49.34 million
Calculation and evidence

-49041000 − 302000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

Exact free cash flow: -49343000 Unit_Standard_USD_P1Q5c4yNx0iQbjIxsZnCsQ

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

56 filings · 2,379 latest values · 2,379 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001408443, 1408443, MIST, edgar:1408443

Also known as MILESTONE PHARMACEUTICALS INC., Milestone Pharmaceuticals Inc., Milestone Pharmaceuticals Inc.